RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 166 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,013 | -23.5% | 27,500 | 0.0% | 0.03% | -23.8% |
| Q2 2023 | $37,950 | +21.6% | 27,500 | +5.8% | 0.04% | +82.6% |
| Q1 2023 | $31,200 | -3.2% | 26,000 | 0.0% | 0.02% | -4.2% |
| Q4 2022 | $32,240 | +79.1% | 26,000 | +4.0% | 0.02% | +84.6% |
| Q3 2022 | $18,000 | -43.8% | 25,000 | 0.0% | 0.01% | -43.5% |
| Q2 2022 | $32,000 | -57.3% | 25,000 | +6.4% | 0.02% | -52.1% |
| Q1 2022 | $75,000 | +31.6% | 23,500 | 0.0% | 0.05% | +33.3% |
| Q4 2021 | $57,000 | -31.3% | 23,500 | 0.0% | 0.04% | -37.9% |
| Q3 2021 | $83,000 | -20.2% | 23,500 | 0.0% | 0.06% | -18.3% |
| Q2 2021 | $104,000 | +30.0% | 23,500 | 0.0% | 0.07% | +20.3% |
| Q1 2021 | $80,000 | +2.6% | 23,500 | +9.3% | 0.06% | -9.2% |
| Q4 2020 | $78,000 | +62.5% | 21,500 | +7.5% | 0.06% | +38.3% |
| Q3 2020 | $48,000 | +71.4% | 20,000 | +29.0% | 0.05% | +62.1% |
| Q2 2020 | $28,000 | +40.0% | 15,500 | +17.0% | 0.03% | +20.8% |
| Q1 2020 | $20,000 | -23.1% | 13,250 | +8.2% | 0.02% | 0.0% |
| Q4 2019 | $26,000 | – | 12,250 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |